Viewing Study NCT02058706


Ignite Creation Date: 2025-12-26 @ 1:16 PM
Ignite Modification Date: 2026-03-04 @ 2:29 PM
Study NCT ID: NCT02058706
Status: COMPLETED
Last Update Posted: 2023-05-10
First Post: 2014-02-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer
Sponsor: Barbara Ann Karmanos Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adenocarcinoma of the Prostate View
None Recurrent Prostate Cancer View
None Stage IV Prostate Cancer View
Keywords: